-+ 0.00%
-+ 0.00%
-+ 0.00%

Anixa Biosciences Advances Ovarian Cancer CAR-T Trial With Major Dose Escalation After Encouraging Survival Data

Reuters·02/09/2026 13:01:51

Please log in to view news